Source:http://linkedlifedata.com/resource/pubmed/id/19673967
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-6-23
|
pubmed:abstractText |
Forty-five days after the first confirmed and fatal Crimean-Congo haemorrhagic fever (CCHF) case in Greece in 2008, a female patient with similar signs and symptoms (high fever, thrombocytopaenia) and resident of the same area, was admitted to the University General Hospital of Alexandroupolis. Before admission, she had visited a local hospital where a cephalosporin was prescribed. A rash manifested over subsequent days, which was misdiagnosed as an allergy to the drug. Upon admission to the University Hospital, she was given further antibiotics, including doxycycline; a few hours later, ribavirin was added because CCHF was suspected. After the patient's death, rickettsiosis caused by Rickettsia conorii conorii (Meditteranean spotted fever; MSF) was diagnosed. Extremely high values of interleukin (IL)-1ra, IL-6, interferon-gamma-inducible protein-10, monocyte chemoattractant protein-1 and an absence of tumour necrosis factor-alpha were observed. MSF is a potentially severe and even fatal disease resembling viral haemorrhagic fevers that has to be included in the differential diagnosis of febrile syndromes combined with thrombocytopaenia, even when a tick bite is not reported, and an eschar is absent. Physicians have to be aware of MSF in patients with severe disease who are returning from the Mediterranean area.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cephalosporins,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1469-0691
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
589-92
|
pubmed:meshHeading |
pubmed-meshheading:19673967-Anti-Bacterial Agents,
pubmed-meshheading:19673967-Antiviral Agents,
pubmed-meshheading:19673967-Boutonneuse Fever,
pubmed-meshheading:19673967-Cephalosporins,
pubmed-meshheading:19673967-Cytokines,
pubmed-meshheading:19673967-Doxycycline,
pubmed-meshheading:19673967-Fatal Outcome,
pubmed-meshheading:19673967-Female,
pubmed-meshheading:19673967-Greece,
pubmed-meshheading:19673967-Humans,
pubmed-meshheading:19673967-Middle Aged,
pubmed-meshheading:19673967-Ribavirin,
pubmed-meshheading:19673967-Rickettsia conorii
|
pubmed:year |
2010
|
pubmed:articleTitle |
Fatal Mediterranean spotted fever in Greece.
|
pubmed:affiliation |
First Department of Microbiology, Medical School, Aristotle University of Thessaloniki, WHO Collaborating Centre for Reference and Research on Arboviruses and Hemorrhagic Fever Viruses, Thessaloniki. annap@med.auth.gr
|
pubmed:publicationType |
Journal Article,
Case Reports
|